• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名女性患者的 GLA 基因内含子突变导致的安德森-法布里病的经典表型:病例报告。

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report.

机构信息

Department of Nephrology, University of Naples, Federico II, Italy.

出版信息

BMC Cardiovasc Disord. 2012 Jun 8;12:39. doi: 10.1186/1471-2261-12-39.

DOI:10.1186/1471-2261-12-39
PMID:22682330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3425126/
Abstract

BACKGROUND

Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of a lysosomal hydrolase, the enzyme α-galactosidase A (GLA). This inactivation is responsible for the storage of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. The incidence of disease is estimated at 1:40,000 in the general population, although neonatal screening initiatives have found an unexpectedly high prevalence of genetic alterations, up to 1:3,100, in newborns in Italy, and have identified a surprisingly high frequency of newborn males with genetic alterations (about 1:1,500) in Taiwan.

CASE PRESENTATION

We describe the case of a 40-year-old female patient who presented with transient ischemic attack (TIA), discomfort in her hands, intolerance to cold and heat, severe angina and palpitations, chronic kidney disease. Clinical, biochemical and molecular studies were performed.

CONCLUSIONS

Reported symptoms, peculiar findings in a renal biopsy - the evidence of occasional lamellar inclusions in podocytes and mesangial cells - and left ventricular (LV) hypertrophy, which are considered to be specific features of FD, as well as molecular evaluations, suggested the diagnosis of a classical form of FD.We detected four mutations in the GLA gene of the patient: -10C>T (g.1170C>T), c.370-77_-81del (g.7188-7192del5), c.640-16A>G (g.10115A>G), c.1000-22C>T (g.10956C>T). These mutations, located in promoter and intronic regulatory regions, have been observed in several patients with manifestations of FD. In our patient clinical picture showed a multisystemic involvement with early onset of symptoms, thus suggesting that these intronic mutations can be found even in patients with classical form of FD.

摘要

背景

法布瑞氏病(FD)是一种遗传性代谢紊乱疾病,由溶酶体水解酶α-半乳糖苷酶 A(GLA)部分或完全失活引起。这种失活导致未降解的糖脂在溶酶体中蓄积,随后导致细胞和微血管功能障碍。该病的发病率估计在普通人群中为 1:40000,尽管新生儿筛查计划发现意大利新生儿的基因突变发生率异常高,高达 1:3100,而且在台湾发现基因突变的新生儿男性频率惊人地高(约 1:1500)。

病例介绍

我们描述了一位 40 岁女性患者的病例,她表现为短暂性脑缺血发作(TIA)、手部不适、对冷热不耐受、严重心绞痛和心悸、慢性肾脏病。进行了临床、生化和分子研究。

结论

报告的症状、肾脏活检中的特殊发现-偶尔在足细胞和系膜细胞中出现板层包涵体的证据-以及左心室(LV)肥大,这些被认为是 FD 的特异性特征,以及分子评估,提示诊断为经典型 FD。我们在患者的 GLA 基因中检测到四个突变:-10C>T(g.1170C>T)、c.370-77_-81del(g.7188-7192del5)、c.640-16A>G(g.10115A>G)、c.1000-22C>T(g.10956C>T)。这些突变位于启动子和内含子调控区,已在多个表现为 FD 的患者中观察到。在我们的患者中,临床表现为多系统受累,症状早发,因此提示这些内含子突变甚至可以在经典型 FD 患者中发现。

相似文献

1
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report.一名女性患者的 GLA 基因内含子突变导致的安德森-法布里病的经典表型:病例报告。
BMC Cardiovasc Disord. 2012 Jun 8;12:39. doi: 10.1186/1471-2261-12-39.
2
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.伴有严重心脏表现的法布里病患者新型α-半乳糖苷酶 A 突变。
Gene. 2014 Feb 10;535(2):365-9. doi: 10.1016/j.gene.2013.09.058. Epub 2013 Oct 17.
3
Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.伴有GLA E66Q突变和斑马小体的家族性肥厚性梗阻性心肌病
BMC Cardiovasc Disord. 2016 May 10;16:83. doi: 10.1186/s12872-016-0262-y.
4
Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.由GLA p.Phe113Leu(p.F113L)变异引起的法布里病:男性的自然病史。
Eur J Med Genet. 2020 Feb;63(2):103703. doi: 10.1016/j.ejmg.2019.103703. Epub 2019 Jun 11.
5
Fabry disease: Review and experience during newborn screening.法布瑞氏病:新生儿筛查期间的回顾与经验。
Trends Cardiovasc Med. 2018 May;28(4):274-281. doi: 10.1016/j.tcm.2017.10.001. Epub 2017 Oct 20.
6
An intronic haplotype in α galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke.α半乳糖苷酶A中的一个内含子单倍型与不明原因中风男性的mRNA表达降低有关。
Gene. 2014 Oct 10;549(2):275-9. doi: 10.1016/j.gene.2014.08.004. Epub 2014 Aug 4.
7
First phenotypic description of a female patient with c.610 T > C variant of GLA: a renal-predominant presentation of Fabry disease.首例携带 GLA c.610T > C 变异的女性患者表型描述:Fabry 病的肾脏优势表现。
BMC Med Genet. 2020 Jun 26;21(1):137. doi: 10.1186/s12881-020-01071-5.
8
Identification of a Novel GLA Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype.在以心脏表型为主的法布里病中鉴定出一种新型GLA基因突变,p.Ile239Met。
Int Heart J. 2017 May 31;58(3):454-458. doi: 10.1536/ihj.16-361. Epub 2017 May 12.
9
Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease.鉴定并功能表征首个引起法布里病肾脏变异型的深内含子 GLA 突变(IVS4+1326C>T)。
Orphanet J Rare Dis. 2022 Jun 20;17(1):237. doi: 10.1186/s13023-022-02377-8.
10
Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.在一个患有法布里肾病的韩裔家族中鉴定出一种新型GLA突变(Y88C):病例报告。
BMC Med Genet. 2016 Oct 24;17(1):76. doi: 10.1186/s12881-016-0338-7.

引用本文的文献

1
Fabry disease in female monozygotic twins with complex intronic haplotype variants: a case report.女性同卵双胞胎中伴有复杂内含子单倍型变异的法布里病:病例报告。
BMC Med Genomics. 2024 Oct 7;17(1):245. doi: 10.1186/s12920-024-02021-3.
2
What Is Hidden in Patients with Unknown Nephropathy? Genetic Screening Could Be the Missing Link in Kidney Transplantation Diagnosis and Management.患者的未知肾病中隐藏着什么?基因筛查可能是肾脏移植诊断和管理中的缺失环节。
Int J Mol Sci. 2024 Jan 24;25(3):1436. doi: 10.3390/ijms25031436.
3
Frequency of Fabry disease in a juvenile idiopathic arthritis cohort.

本文引用的文献

1
Genetic screening of Fabry patients with EcoTILLING and HRM technology.采用EcoTILLING和HRM技术对法布里病患者进行基因筛查。
BMC Res Notes. 2011 Sep 6;4:323. doi: 10.1186/1756-0500-4-323.
2
Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study.不明病因小纤维神经病患者中 Fabry 病的频率:一项初步研究。
Eur J Neurol. 2011 Apr;18(4):631-6. doi: 10.1111/j.1468-1331.2010.03227.x. Epub 2010 Sep 23.
3
Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).
法布瑞病在幼年特发性关节炎队列中的频率。
Pediatr Rheumatol Online J. 2021 Jun 12;19(1):91. doi: 10.1186/s12969-021-00563-9.
4
Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients.干血斑中 GLA 变异体与α-半乳糖苷酶 A 谱的相关性:巴西患者的观察性研究。
Orphanet J Rare Dis. 2020 Jan 29;15(1):30. doi: 10.1186/s13023-019-1274-3.
5
Fabry disease. A potential pitfall A family with a novel intronic mutation.法布里病。一个潜在的陷阱。一个携带新型内含子突变的家族。
Mol Genet Metab Rep. 2018 Sep 8;17:16-17. doi: 10.1016/j.ymgmr.2018.07.001. eCollection 2018 Dec.
6
Restoring functional neurofibromin by protein transduction.通过蛋白质转导恢复功能性神经纤维瘤蛋白。
Sci Rep. 2018 Apr 18;8(1):6171. doi: 10.1038/s41598-018-24310-5.
7
Fabry disease in the Spanish population: observational study with detection of 77 patients.西班牙人群中的法布里病:77 例患者的观察性研究。
Orphanet J Rare Dis. 2018 Apr 10;13(1):52. doi: 10.1186/s13023-018-0792-8.
8
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.血浆溶菌酶糖脂酰基鞘氨醇作为生物标志物用于从多学科诊所选择进行基因分析的法布雷病高危患者的有效性。
Genet Med. 2019 Jan;21(1):44-52. doi: 10.1038/gim.2018.31. Epub 2018 Mar 15.
9
Low frequency of Fabry disease in patients with common heart disease.常见心脏病患者中 Fabry 病的发病率较低。
Genet Med. 2018 Jul;20(7):754-759. doi: 10.1038/gim.2017.175. Epub 2017 Oct 26.
10
Identification of Cryptic Novel α-Galactosidase A Gene Mutations: Abnormal mRNA Splicing and Large Deletions.隐匿性新型α-半乳糖苷酶A基因突变的鉴定:异常mRNA剪接和大片段缺失
JIMD Rep. 2016;30:63-72. doi: 10.1007/8904_2015_475. Epub 2016 Jun 3.
台湾地区对法布里病进行的新生儿筛查显示,迟发型GLA突变c.936+919G>A(IVS4+919G>A)的发病率很高。
Hum Mutat. 2009 Oct;30(10):1397-405. doi: 10.1002/humu.21074.
4
Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study.酶替代疗法对安德森-法布里病患者的影响:一项前瞻性长期心脏磁共振成像研究。
Heart. 2009 Jul;95(13):1103-7. doi: 10.1136/hrt.2008.162800. Epub 2009 Apr 15.
5
Alternative splicing and disease.可变剪接与疾病
Biochim Biophys Acta. 2009 Jan;1792(1):14-26. doi: 10.1016/j.bbadis.2008.09.017. Epub 2008 Oct 17.
6
The g.1170C>T polymorphism of the 5' untranslated region of the human alpha-galactosidase gene is associated with decreased enzyme expression--evidence from a family study.人α-半乳糖苷酶基因 5'非翻译区 g.1170C>T 多态性与酶表达降低相关——来自家系研究的证据。
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S405-13. doi: 10.1007/s10545-008-0972-0. Epub 2008 Nov 3.
7
Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease.通过实时PCR定量法布里病患者成纤维细胞中不平衡的GLA mRNA比率会导致法布里病。
Eur J Hum Genet. 2008 Nov;16(11):1311-7. doi: 10.1038/ejhg.2008.109. Epub 2008 Jun 18.
8
MRI characterization of myocardial tissue in patients with Fabry's disease.法布里病患者心肌组织的磁共振成像特征
AJR Am J Roentgenol. 2007 Mar;188(3):850-3. doi: 10.2214/AJR.05.0442.
9
High incidence of later-onset fabry disease revealed by newborn screening.新生儿筛查显示迟发型法布里病的高发病率。
Am J Hum Genet. 2006 Jul;79(1):31-40. doi: 10.1086/504601. Epub 2006 Apr 28.
10
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.法布里杂合子中X染色体失活与临床受累情况的关系。捷克和斯洛伐克人群中α-半乳糖苷酶A基因的11种新突变。
J Mol Med (Berl). 2005 Aug;83(8):647-54. doi: 10.1007/s00109-005-0656-2. Epub 2005 Apr 2.